Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Halama

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Oncoimmunology|September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
British Journal of Haematology|September 20, 2011
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implicationsKlaus Podar, Alexander Zimmerhackl, Mariateresa Fulciniti, et al.
Journal for Immunotherapy of Cancer|October 5, 2021
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effectsMeggy Suarez-Carmona, Anja Williams, Jutta Schreiber, et al.
Glia|January 20, 2018
Astrocytic glutamine synthetase is expressed in the neuronal somatic layers and down-regulated proportionally to neuronal loss in the human epileptic hippocampusIsmini E Papageorgiou, Nektarios A Valous, Bernd Lahrmann, et al.
International Journal of Cancer|November 13, 2014
Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic miceAdriane Gardyan, Wolfram Osen, Inka Zörnig, et al.
International Journal of Cancer|May 20, 2014
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patientsInka Zörnig, Niels Halama, Justo Lorenzo Bermejo, et al.
Oncoimmunology|June 7, 2018
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trialJudith Michels, Natalia Becker, Stefan Suciu, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer PatientCarlo Fremd, Mario Hlevnjak, Marc Zapatka, et al.
STAR Protocols|May 5, 2026
Protocol for natural and biomedical image processing in the hypercomplex domain using the 2D orthogonal planes splitNektarios A Valous, Eckhard Hitzer, Dragoş Duşe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Seromic profiling of ovarian and pancreatic cancerSacha Gnjatic, Erika Ritter, Markus W Büchler, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Oncoimmunology|September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
British Journal of Haematology|September 20, 2011
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implicationsKlaus Podar, Alexander Zimmerhackl, Mariateresa Fulciniti, et al.
Journal for Immunotherapy of Cancer|October 5, 2021
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effectsMeggy Suarez-Carmona, Anja Williams, Jutta Schreiber, et al.
Glia|January 20, 2018
Astrocytic glutamine synthetase is expressed in the neuronal somatic layers and down-regulated proportionally to neuronal loss in the human epileptic hippocampusIsmini E Papageorgiou, Nektarios A Valous, Bernd Lahrmann, et al.
International Journal of Cancer|November 13, 2014
Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic miceAdriane Gardyan, Wolfram Osen, Inka Zörnig, et al.
International Journal of Cancer|May 20, 2014
Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patientsInka Zörnig, Niels Halama, Justo Lorenzo Bermejo, et al.
Oncoimmunology|June 7, 2018
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trialJudith Michels, Natalia Becker, Stefan Suciu, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer PatientCarlo Fremd, Mario Hlevnjak, Marc Zapatka, et al.
STAR Protocols|May 5, 2026
Protocol for natural and biomedical image processing in the hypercomplex domain using the 2D orthogonal planes splitNektarios A Valous, Eckhard Hitzer, Dragoş Duşe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Seromic profiling of ovarian and pancreatic cancerSacha Gnjatic, Erika Ritter, Markus W Büchler, et al.
Pageof 12